Canon US Life Sciences researchers have developed a rapid assay based on high-resolution melting analysis to accurately genotype 23 mutations in the cystic fibrosis transmembrane conductance regulator gene responsible for CF and related disorders.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.